Daniel J Margolin, MD in Lenexa, KS - General Practice

Daniel J Margolin, MD is a General Practice physician based in Lenexa, Kansas. Daniel J Margolin is licensed to practice in Kansas (license number 04-34103) and his current practice location is 15545 W 87th Street Pkwy, Lenexa, Kansas. He can be reached at his office (for appointments etc.) via phone at (913) 894-4428.

NPI number for Daniel J Margolin is 1396763421 and his current mailing address is 15545 W 87th Street Pkwy, Lenexa, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1396763421.

Contact Information

	Daniel J Margolin, MD
	15545 W 87th Street Pkwy, Lenexa, KS 66219-1434
	(913) 894-4428
	Not Available

Physician's Profile

Full Name	Daniel J Margolin
Gender	Male
Speciality	General Practice
Location	15545 W 87th Street Pkwy, Lenexa, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1396763421
Provider Enumeration Date: 07/17/2006
Last Update Date: 04/15/2022

Medical Identifiers

Medical identifiers for Daniel J Margolin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1396763421	NPI	-	NPPES
200309650A	Medicaid	KS
207330200	Medicaid	MO

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	2004005751 (Missouri)	Secondary
208D00000X	General Practice	04-34103 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Daniel J Margolin is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Daniel J Margolin, MD 15545 W 87th Street Pkwy, Lenexa, KS 66219-1434 Ph: (913) 894-4428	Daniel J Margolin, MD 15545 W 87th Street Pkwy, Lenexa, KS 66219-1434 Ph: (913) 894-4428

News Archive

Medicare documentation requirements for power wheelchairs must be improved, federal report

A federal report released last week on Medicare claims for power wheelchairs confirms that the regulatory documentation requirements are confusing, onerous, and must be improved, says the American Association for Homecare, the nation's largest association representing providers of durable medical equipment and services, including wheelchairs.

ChondroGene and Pfizer osteoarthritis collaboration

ChondroGene reported today that it has entered into a new two-year research collaboration with Pfizer for the identification of novel therapeutic targets and biomarkers for the treatment and diagnosis of osteoarthritis (OA).

GATTEX Phase 3 pivotal study reaches primary efficacy endpoint of reducing PN in patients with SBS

NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced that its Phase 3 pivotal study of GATTEX met the primary efficacy endpoint of reducing parenteral nutrition dependence in patients with adult short bowel syndrome.

Eurotrans-Bio awards 1.1 million grant to MDxHealth, NovioGendix for bladder cancer program

MDxHealth SA, a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that together with partner NovioGendix B.V., a molecular diagnostics company spun out from Radboud University Nijmegen Medical Centre, the Netherlands, has received a USD 1.1 million grant from Eurotrans-Bio to progress its bladder cancer program.

Study: 172K polymorphism makes certain forms of HIV less resistant to drugs

The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals.

Daniel J Margolin, MD - General Practice in Lenexa, KS